Search

Search Constraints

You searched for: Author/Creator Enzmann, Harald

Search Results

1. Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation. Issue 4 (1st October 2019)

4. Combinations in the first-line treatment of patients with advanced/metastatic renal cell cancer: regulatory aspects. Issue 4 (26th August 2020)

7. EMA Review of Acalabrutinib for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia. (10th February 2021)

8. EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma. (23rd November 2020)

9. EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma. (16th October 2020)

10. EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma. (19th July 2021)